Form 4 for RIGL RIGEL PHARMACEUTICALS INC
Accepted 2025-02-06 00:00:00 ET · period of report 2025-02-04 · accession 0000905148-25-000413 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-02-06 | 2025-02-04+ | RIGL | Schorno Dean L | EVP, CFO | S - Sale | $21.38 | -3,770 | 57.2K | -6% | -$80.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-04 | S | D | 2,036 | $20.92 | 58,969 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-05 | S | D | 1,734 | $21.93 | 57,235 | D | — | — |